Sangamo Therapeutics (SGMOQ) Net Income towards Common Stockholders (QoQ) (2010 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Net Income towards Common Stockholders (QoQ) (2010 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.13 Bn | 9.29 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.23 Bn | 5.23 Bn | - |
| 3 | Iovance Biotherapeutics | 3.82 Bn | 3.52 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.72 Bn | 251.50 Mn |
| 5 | uniQure | 3.08 Bn | 3.08 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.54 Bn | 251.87 Mn |
| 9 | Vericel | 2.00 Bn | 1.84 Bn | 56.40 Mn |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -7.13% |
| Sep 30, 2025 | -74.77% |
| Jun 30, 2025 | 34.68% |
| Mar 31, 2025 | -30.78% |
| Dec 31, 2024 | -349.29% |
| Sep 30, 2024 | 125.98% |
| Jun 30, 2024 | 26.40% |
| Mar 31, 2024 | 18.59% |
| Dec 31, 2023 | 42.11% |
| Sep 30, 2023 | 9.03% |
| Jun 30, 2023 | -641.84% |
| Mar 31, 2023 | 140.68% |
| Dec 31, 2022 | 2.28% |
| Sep 30, 2022 | -23.12% |
| Jun 30, 2022 | 1.92% |
| Mar 31, 2022 | -17.48% |
| Dec 31, 2021 | 21.43% |
| Sep 30, 2021 | -1.10% |
| Jun 30, 2021 | -2.68% |
| Mar 31, 2021 | -12.94% |